Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
about
Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococciPharmacokinetics and safety of recently approved drugs used to treat methicillin-resistant Staphylococcus aureus infections in infants, children and adults.Genetic transformation of Diaporthe phaseolorum, an endophytic fungus found in mangrove forests, mediated by Agrobacterium tumefaciens.3-hydroxypropionic acid as an antibacterial agent from endophytic fungi Diaporthe phaseolorum.New drugs approved in 2010Efficacy of human simulated exposures of ceftaroline administered at 600 milligrams every 12 hours against phenotypically diverse Staphylococcus aureus isolatesActivity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia.Ceftaroline in complicated skin and skin-structure infections.Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms.Single- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjectsStructure-Activity Relationship for the 4(3H)-Quinazolinone AntibacterialsAntimicrobial susceptibility patterns of Streptococcus pneumoniae over 6 years at Gondar University Hospital, Northwest Ethiopia.Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience.Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA.Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.New antibiotics for bad bugs: where are we?β-lactam/β-lactamase inhibitor combinations: from then to now.Ceftaroline fosamil for the treatment of hospital-acquired pneumonia and ventilator-associated pneumonia.Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.The structural modification of natural products for novel drug discovery.Antimicrobial activity of ceftaroline tested against drug-resistant subsets of Streptococcus pneumoniae from U.S. medical centers.Mycotic pseudoaneurysm by vancomycin-intermediate Staphylococcus aureus: a rare cause of persistent bacteraemia.Potential of Staphylococcus aureus isolates carrying different PBP2a alleles to develop resistance to ceftaroline.Benzotriazole-Mediated Synthesis and Antibacterial Activity of Novel N-Acylcephalexins.Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types.Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance program.Ceftaroline fosamil: A novel anti-Methicillin-resistant Staphylococcus aureus cephalosporin.AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.Ceftaroline Resistance by Clone-Specific Polymorphism in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus
P2860
Q26853465-0BD1D022-C21B-41F2-9502-36BBFBB7EDF1Q33657212-2BB681D1-817E-43EE-A68D-534ED71B7692Q34115120-196A2671-B866-4542-965E-1254F979B62AQ34377270-7C76A7DF-C373-40A0-BDE8-B4963FE693C9Q34753085-3BF50895-47A7-4D08-A849-CCD5353D31CEQ35191501-8B703EC7-E437-49E4-B7AC-3732385AA918Q35191527-ED8FBFCA-AF1C-4409-9A43-232742C62890Q35408518-B9DE3A92-0674-47D2-AC3E-FFAB29434F56Q35715381-92B89CC7-866A-40C9-A5CF-349320B0A85EQ35901841-5569E19D-DDAD-4A16-958E-B30278C37CCDQ36667104-3F8650AD-9629-46AB-954E-E83E9A9A7752Q36947075-6F66CDFA-3FF6-49A2-B7AC-00CD515479A2Q36963512-6C21D1B7-CB12-4A4E-BB53-8F1C9268D282Q37426237-BB0C9F44-9265-448E-8437-ECFC592495F9Q38061168-703B7B2A-EAE7-42A3-BD28-55113A689731Q38117077-C94A0443-A237-41FA-8E06-34E6141A213CQ38132217-6FB2202C-0343-49EC-A186-EBE7988E6B26Q38264182-874A6D90-AAAD-47E3-AD89-9065AA2A02B0Q38468392-B67B9B2A-DA54-4A13-93B0-68E74DFF28A5Q39048083-E030FC05-5548-4E99-8A96-6973028DEC87Q39050184-CAD504A8-2746-4F09-A4AB-28A3EE58A496Q39682573-B06FFE89-FF73-430B-9AF5-F72D09AE4C2EQ39756604-32623C14-9063-4D06-B1CC-321877A4D4F0Q40944820-CFE15518-D3DA-4622-B5BC-69F4CEFC8B91Q41461489-0424DF55-4317-474D-92E8-E42FC5F48F2DQ41919138-0D8CE449-0DFC-4484-973E-4328A487FEA7Q41984202-5A0B374C-867C-49AF-BC28-7A36EA094815Q42869521-E9703957-966E-4068-A883-A097DE0151ADQ50916931-485DF84C-23E5-4B89-A788-F6FA11E0F35CQ57210839-ED11C2D6-9DD3-450D-AE48-522FE775D2E1
P2860
Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Ceftaroline fosamil: a novel b ...... d anti-Gram-positive activity.
@en
Ceftaroline fosamil: a novel b ...... d anti-Gram-positive activity.
@nl
type
label
Ceftaroline fosamil: a novel b ...... d anti-Gram-positive activity.
@en
Ceftaroline fosamil: a novel b ...... d anti-Gram-positive activity.
@nl
prefLabel
Ceftaroline fosamil: a novel b ...... d anti-Gram-positive activity.
@en
Ceftaroline fosamil: a novel b ...... d anti-Gram-positive activity.
@nl
P2093
P356
P1476
Ceftaroline fosamil: a novel b ...... d anti-Gram-positive activity.
@en
P2093
Dirk A Thye
Donald Biek
Ian A Critchley
Todd A Riccobene
P304
P356
10.1093/JAC/DKQ251
P407
P478
65 Suppl 4
P577
2010-11-01T00:00:00Z